Invesco Biotechnology & Genome ETF
PBE
PBE
89 hedge funds and large institutions have $56.5M invested in Invesco Biotechnology & Genome ETF in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
54% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 28
Holders
89
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$556K | |
| 2 | +$369K | |
| 3 | +$336K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$311K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$286K |
Top Sellers
| 1 | -$2.62M | |
| 2 | -$1.91M | |
| 3 | -$1.21M | |
| 4 |
PA
PFG Advisors
Phoenix,
Arizona
|
-$1.21M |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.07M |